HealthQuill Resectable Cancer
AstraZenecaā€™s combination drug for the treatment of adults with resectable non-small cell lung cancer has got approval from the European Union.
Drugs Health Pharma

AstraZenecaā€™s lung cancer drug combination gets EU approvalĀ 

HQ Team April 4, 2025: AstraZenecaā€™s combination drug for the treatment of adults with resectable non-small cell lung cancer has got approval from.

Read More